Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

12/08/2022 07:05

Aug 12 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2022        Jun 30, 2021       Mar 31, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales                                100 mln           300 mln     
                (-100.0 pct)                            (+0.0 pct)   
  Operating     loss 304 mln        loss 304 mln        loss 1.15    
  Recurring     loss 307 mln        loss 306 mln        loss 1.15    
  Net           loss 308 mln        loss 306 mln        loss 1.15    
  EPS          loss 56.96 yen      loss 56.76 yen    loss 212.20 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T